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Uninvestigated dyspepsiaAbstract Uninvestigated dyspepsia (UD), irritable bowel syndrome (IBS), and gas-
troesophageal reflux disease (GERD) are common disorders universally. Many studies
have assessed their epidemiological characteristics around the world. However,
such information is not known for Syria. We aim to estimate the epidemiologic char-
acteristics and possible risk factors for UD, IBS, and GERD among students at Dam-
ascus University, Damascus, Syria. A cross-sectional study was conducted in July–
September 2015 at a campus of Damascus University. A total of 320 students were
randomly asked to complete the survey. We used ROME III criteria to define UD
and IBS, and Montreal definition for GERD. In total, 302 valid participants were
included in the analysis. Prevalence for UD, IBS, and GERD was 25%, 17%, and
16%, respectively. Symptom overlap was present in 46 students (15%), with UD
+ IBS in 28 (9.3%), UD + GERD in 26 (8.6%), and IBS + GERD in 14 (4.6%) students.
Eleven (3.6%) students had symptoms of UD + IBS + GERD. Each of these overlaps
occurred more frequently than expected by chance. Significant risk factors included
cigarettes smoking, waterpipe consumption, and body mass index <18.5 kg/m2 for
UD; female gender and three cups of coffee/d for IBS; and two cups of tea andl.: +963
286 T. Al Saadi et al.one to five cigarettes/d for GERD. Risk factors for these disorders remain poorly
characterized and need further investigations.
 2016 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Gastrointestinal (GI) diseases are very frequent in
the daily practice of medicine [1] and have a signif-
icant impact on patients’ quality of life [2]. Several
studies have estimated the prevalence of those dis-
eases, described their signs and symptoms, and
studied the factors associated with them.
Dyspepsia refers to a group of GI symptoms that
includes epigastric pain, fullness, and nausea.
Uninvestigated dyspepsia (UD) generally refers to
the dyspepsia which is not investigated by any
medical test (such as upper GI endoscopy) and is
not determined to be functional or organic in etiol-
ogy. The global prevalence of UD varies between
7% and 45% in epidemiological studies [3]. In Asia,
however, the prevalence of UD varies between 8%
and 30% [4]. This variation in the prevalence esti-
mates might be due to differences in the definition
used in recognizing the disorder and differences in
geographical locations [3,4].
Irritable bowel syndrome (IBS) is a common
functional GI disorder. It is characterized by
abdominal pain or discomfort with altered bowel
habits, but without any organic damages such as
tumor or inflammation [5]. The prevalence of IBS
is estimated to be between 10% and 15% in Western
countries [6] and between 5% and 10% in Asia [7].
The Montreal consensus defines gastroe-
sophageal reflux disease (GERD) as a condition that
develops when the reflux of gastric contents causes
troublesome symptoms and/or complications [8].
Epidemiological studies classified GERD as the most
common GI diagnosis in the outpatient setting [9].
Prevalence and epidemiological characteristics
of UD, IBS, and GERD are unknown in Syria. As part
of increasing physicians’ ability of symptoms-based
approach to such diseases, we have taken the
opportunity to study the prevalence and risk fac-
tors of those common GI diseases among students
of Damascus University, Damascus, Syria.2. Materials and methods
2.1. Study design
A cross-sectional study regarding the prevalence
and risk factors of three GI disorders: UD, IBS,and GERD, was held between July 2015 and
September 2015 at the campus of Damascus
University.
2.2. Participants
Participants of the study were students, both
undergraduates and graduates, at Damascus
University, ranging in age from 18 years to
33 years. A total of 320 students were randomly
recruited for the study. Unreturned or incomplete
papers were excluded, and only 302 participants
were included in the analysis.
2.3. Data collection
Students were asked to voluntarily complete a pre-
designed questionnaire that was structured by the
researchers; trained staff answered participants’
questions on the spot. The objectives of the study
were explained to the participants, and they were
informed that their participation was voluntary and
anonymous. All included participants gave an
informed consent prior to data collection. Ethical
approval of this study was obtained from the Ethics
Committee of the Faculty of Medicine, Damascus
University.
2.4. The questionnaire
The questionnaire was designed to collect the fol-
lowing data: demographics (age and gender), gen-
eral health [weight and height, to calculate body
mass index (BMI)], lifestyle-related factors (con-
sumption of tea, coffee, fatty food, alcohol, cigar-
ettes, waterpipe, and NSAIDs), and physical
symptoms related to GI disorders (such as epigas-
tric pain, burning sensation, diarrhea, etc.).
Dyspepsia and IBS were assessed according to
the ROME III criteria [5], while GERD was evaluated
according to the Montreal definition [8].
UD was not directly addressed by the Rome III
criteria. Rather, Rome III defines criteria for func-
tional dyspepsia (FD), which necessitates perform-
ing upper GI endoscopy to rule out structural
disease. We depended on the symptoms that were
defined for FD by the Rome III criteria in order to
recognize those with dyspepsia, and since no upper
GI endoscopy was performed, patients who fulfill
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UD. Consequently, individuals were classified as
having dyspepsia if they reported experiencing at
least one of the following symptoms: (1) bother-
some postprandial fullness; (2) early satiation; (3)
epigastric pain; and (4) epigastric burning. All the
above criteria should be fulfilled for the last
3 months with symptoms onset at least 6 months
prior to diagnosis.
Classification of IBS was made according to
report of abdominal pain or discomfort persisting
for at least 3 days, at least once a month during
the previous 3 months, and accompanied by at least
two of the following symptoms: (1) relief of pain or
discomfort attained after defecation; (2) onset of
pain or discomfort associated with a change in stool
frequency; or (3) onset of pain or discomfort associ-
ated with a change in stool appearance.
Individuals were classified as having GERD if they
reported experiencing frequent episodes of heart-
burn or acid regurgitation occurring at least twice
a week for mild symptoms or once a week for mod-
erate to severe symptoms.
For each of the GI disorders, the survey ques-
tions were translated from the original source into
the Arabic language by the authors. Any individual
classified with two or more of the above disorders
was categorized as ‘‘GI symptom complex
overlap”.
2.5. Statistical analysis
All eligible questionnaires were coded. Data were
expressed as frequencies or means with standard
deviations (SD). The v2 test was used to investigate
the association between possible risk factors and
each of the investigated disorders. Possible risk fac-
tors were assessed again using binary logistic
regression analysis, and the results were expressed
as p values, along with the corresponding odds
ratios (OR) and 95% confidence intervals (CI) in
cases of significant associations. Exact binomial
test for proportions was used to compare the
observed prevalence to the calculated prevalence.
Calculated p values for v2 and binary logisticTable 1 Characteristics of students with the investigated gas
Total (n = 302) Normal (n =
Gender Female 196 (64.9) 123 (66.1)
Male 106 (35.1) 63 (33.9)
Age (y) 21.6 ± 1.9 21.7 ± 1.9
BMI (kg/m2) 22.6 ± 3.9 22.7 ± 4.0
Data are presented as n (%) or mean ± standard deviation.
BMI = body mass index; GERD = gastroesophageal reflux disease; IBregression test were two-tailed, while calculated
p values for the exact binomial test were single-
tailed. A p value <0.05 was considered statistically
significant. All statistical analyses were carried
out with SPSS version 22.0 (SPSS Inc., Chicago, IL,
USA).
3. Results
Of the 320 students recruited in the study, 18 stu-
dents refused to participate or did not complete
the survey. A total of 302 valid participants were
included in the analysis. Demographic data for each
group of participants (normal healthy participants,
those who have UD, those who have IBS, and those
who have GERD) are summarized in Table 1. Over-
all, the study included 196 females (64.9%) and
106 males (35.1%). Participants had a mean (±SD)
age of 21.6 ± 1.9 years. BMI was investigated for
all participants as a possible risk factor for the dis-
orders being investigated. The overall mean (±SD)
BMI for the participants was 22.6 ± 3.9 kg/m2.
There were 186 participants (61%) who did not
have any of the three investigated GI disorders;
they were classified as normal participants. UD
affected 75 participants, while IBS affected 50 par-
ticipants, and GERD affected 48 participants. The
prevalences for those three disorders in the study
sample were 25%, 17%, and 16%, respectively
(Fig. 1). There were no clinically significant differ-
ences in the mean age or mean BMI between the
participants classified in each disorder group and
those who are classified in the normal group
(Table 1).
GI symptom complex overlap was present in 46
students (15%), with UD + IBS in 28 students
(9.3%), UD + GERD in 26 students (8.6%), and IBS
+ GERD in 14 students (4.6%). Eleven students
(3.6%) had symptoms of all three investigated dis-
orders (UD + IBS + GERD; Fig. 2). The expected
prevalence of the overlap between each group of
disorders was calculated by multiplying the preva-
lences of the overlap components, assuming those
components were independent diseases. The true
observed prevalence was compared to the calcu-trointestinal disorders.
186) UD (n = 75) IBS (n = 50) GERD (n = 48)
49 (65.3) 39 (78.0) 27 (56.3)
26 (34.7) 11 (22.0) 21 (43.8)
21.4 ± 1.5 21.7 ± 2.2 21.6 ± 1.6
22.0 ± 3.7 21.8 ± 3.2 23.2 ± 4.0
S = irritable bowel syndrome; UD = uninvestigated dyspepsia.
Fig. 1 Prevalences of the investigated gastrointestinal disorders in the study sample. GERD = gastroesophageal reflux
disease; IBS = irritable bowel syndrome; UD = uninvestigated dyspepsia.
Table 2 Relationship between the investigated gastrointestin
Observed prevalence
UD and IBS 28 (9.3)
UD and GERD 26 (8.6)
IBS and GERD 14 (4.6)
UD and IBS and GERD 11 (3.6)
Data are presented as n (%).
p value is for the exact binomial test for proportions that compa
sponding pair of subgroups.
GERD = gastroesophageal reflux disease; IBS = irritable bowel syndr
a Assuming the corresponding pair of subgroups was independent
* p < 0.05.
Fig. 2 Overlaps in prevalence of the investigated
gastrointestinal disorders in the study sample.
GERD = gastroesophageal reflux disease; IBS = irritable
bowel syndrome; UD = uninvestigated dyspepsia.
288 T. Al Saadi et al.lated prevalence using the exact binomial test for
proportions. All comparisons yielded statistically
significant p values, indicating that each overlap
had occurred more frequently than expected by
chance (Table 2).
Tables 3–5 summarize demographic and life-
style characteristics of the participants and their
statistical relationship with UD, IBS, and GERD,
respectively.
Among the investigated factors, cigarette smok-
ing and waterpipe consumption were significantly
related to UD (p = 0.019 and p = 0.034, respec-
tively). Having a BMI < 18.5 kg/m2 was significantly
associated with UD after controlling for other pos-
sible factors (p = 0.038, OR = 2.365, 95% CI: 1.048–
5.336).
Female gender was significantly associated with
IBS in the study sample (p = 0.034). However, there
was no significant difference in IBS prevalence
among females compared to males after control-
ling for other possible factors (p = 0.096). Drinking
three cups of coffee/d was significantly associated
with IBS after controlling for other possible factors






red the observed vs. the expected prevalence of each corre-
ome; UD = uninvestigated dyspepsia.
.
Table 3 Association of demographic- and lifestyle-related factors with uninvestigated dyspepsia.
UD v2, df, p Binary logistic
regression (p)No. %
Gender Male 26 34.7 0.008, 1, 0.928 —
Female 49 65.3 0.931
Age (y) 18–21 41 54.7 2.729, 2, 0.255 —
22–25 34 45.3 0.717
>25 0 0.0 0.999
BMI (kg/m2) 18.5–24.9 (normal) 43 57.3 5.620, 3, 0.132 —
<18.5 (underweight) 14 18.7 0.038*
25–30 (overweight) 16 21.3 0.456
>30 (obese) 2 2.7 0.224
Tea intake (cups/d) 0 10 13.3 3.339, 4, 0.503 —
1 26 34.7 0.699
2 24 32.0 0.448
3 8 10.7 0.827
>3 7 9.3 0.970
Coffee intake (cups/d) 0 19 25.3 2.147, 4, 0.709 —
1 35 46.7 0.404
2 11 14.7 0.829
3 6 8.0 0.165
>3 4 5.3 0.637
Fatty food consumption
(average frequency/wk)
0 0 0.0 7.312, 4, 0.120 —
1 12 16.0 0.999
2 28 37.3 0.999
3 20 26.7 0.999
>3 15 20.0 0.999
Alcohol consumption (cups/wk) 0 72 96.0 2.291, 3, 0.514 —
1 2 2.7 0.919
2 0 0.0 0.999
3 0 0.0 0.999
>3 1 1.3 0.999
Cigarettes consumption
(No. of cigarettes/d)
0 67 89.3 13.560, 5, 0.019* —
1–5 3 4.0 0.334
6–10 1 1.3 0.999
11–15 0 0.0 0.999
16–20 1 1.3 0.995
>20 3 4.0 0.999
Waterpipe consumption
(average frequency/wk)
0 60 80.0 10.400, 4, 0.034* —
1 8 10.7 0.526
2 0 0.0 0.998
3 3 4.0 0.062
>3 4 5.3 0.401
Regular NSAIDs intake (pills/mo) 0–5 63 84.0 3.290, 4, 0.510 —
6–10 9 12.0 0.889
11–15 1 1.3 0.874
16–20 2 2.7 0.196
>20 0 0.0 1.000
BMI = body mass index; df = degree of freedom; NSAIDs = nonsteroidal antiinflammatory drugs; UD = uninvestigated dyspepsia.
* p < 0.05; for the v2 or binary logistic regression test investigating the association between each risk factor and uninvestigated
dyspepsia.
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Table 4 Association of demographic- and lifestyle-related factors with irritable bowel syndrome.
IBS v2, df, p Binary logistic
regression (p)No. %
Gender Male 11 22.0 4.514, 1, 0.034* —
Female 39 78.0 0.096
Age (y) 18–21 26 52.0 0.123, 2, 0.941 —
22–25 23 46.0 0.594
>25 1 2.0 0.452
BMI (kg/m2) 18.5–24.9 (normal) 34 68.0 1.076, 3, 0.783 —
<18.5 (underweight) 6 12.0 0.551
25–30 (overweight) 9 18.0 0.985
>30 (obese) 1 2.0 0.341
Tea intake (cups/d) 0 8 16.0 0.559, 4, 0.967 —
1 16 32.0 0.774
2 14 28.0 0.767
3 8 16.0 0.621
>3 4 8.0 0.807
Coffee intake (cups/d) 0 15 30.0 5.744, 4, 0.219 —
1 20 40.0 0.426
2 6 12.0 0.131
3 7 14.0 0.039*
>3 2 4.0 0.293
Fatty food consumption
(average frequency/wk)
0 0 0.0 4.046, 4, 0.400 —
1 8 16.0 0.999
2 19 38.0 0.999
3 14 28.0 0.999
>3 9 18.0 0.999
Alcohol consumption (cups/wk) 0 50 100 2.052, 3, 0.562 —
1 0 0.0 0.999
2 0 0.0 0.999
3 0 0.0 0.999
>3 0 0.0 1.000
Cigarettes consumption
(No. of cigarettes/d)
0 50 100 4.708, 5, 0.453 —
1–5 0 0.0 0.999
6–10 0 0.0 0.999
11–15 0 0.0 0.999
16–20 0 0.0 0.999
>20 0 0.0 0.999
Waterpipe consumption
(average frequency/wk)
0 41 82.0 3.199, 4, 0.525 —
1 5 10.0 0.065
2 0 0.0 0.999
3 1 2.0 0.593
>3 3 6.0 0.187
Regular NSAIDS intake (pills/mo) 0–5 41 82.0 5.822, 4, 0.213 —
6–10 6 12.0 0.684
11–15 1 2.0 0.688
16–20 2 4.0 0.060
>20 0 0.0 1.000
BMI = body mass index; df = degree of freedom; IBS = irritable bowel syndrome; NSAIDs = nonsteroidal antiinflammatory drugs.
* p < 0.05; for the v2 or binary logistic regression test investigating the association between each risk factor and irritable bowel
syndrome.
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two cups of tea (p = 0.010, OR = 6.872, 95% CI:
1.579–29.901) and smoking one to five cigarettes/
d (p = 0.044, OR = 7.191, 95% CI: 1.056–48.993)
after controlling for other possible factors.4. Discussion
In this study, we investigated the prevalence, asso-
ciated risk factors, and overlap of three common GI
disorders (UD, IBS, and GERD) among Syrian
Table 5 Association of demographic- and lifestyle-related factors with gastroesophageal reflux disease.
GERD v2, df, p Binary logistic
regression (p)Number %
Gender Male 21 43.8 1.875, 1, 0.171 —
Female 27 56.3 0.259
Age (y) 18–21 25 52.1 0.089, 2, 0.957 —
22–25 22 45.8 0.752
>25 1 2.1 0.616
BMI (kg/m2) 18.5–24.9 (normal) 33 68.8 2.047, 3, 0.563 —
<18.5 (underweight) 3 6.3 0.230
25–30 (overweight) 9 18.8 0.428
>30 (obese) 3 6.3 0.903
Tea intake (cups/d) 0 3 6.3 5.768, 4, 0.217 —
1 17 35.4 0.055
2 17 35.4 0.010*
3 6 12.5 0.253
>3 5 10.4 0.154
Coffee intake (cups/d) 0 17 35.4 2.958, 4, 0.565 —
1 18 37.5 0.224
2 5 10.4 0.087
3 4 8.3 0.760
>3 4 8.3 0.865
Fatty food consumption
(average frequency/wk)
0 1 2.1 3.290, 4, 0.511 —
1 11 22.9 0.546
2 15 31.3 0.678
3 10 20.8 0.796
>3 11 22.9 0.239
Alcohol consumption (cups/wk) 0 46 95.8 1.128, 3, 0.770 —
1 1 2.1 0.558
2 1 2.1 0.220
3 0 0.0 0.999
>3 0 0.0 0.999
Cigarettes consumption
(No. of cigarettes/d)
0 42 87.5 8.447, 5, 0.133 —
1–5 3 6.3 0.044*
6–10 1 2.1 0.193
11–15 1 2.1 0.287
16–20 1 2.1 0.776
>20 0 0.0 0.999
Waterpipe consumption
(average frequency/wk)
0 39 81.3 3.740, 4, 0.442 —
1 4 8.3 0.755
2 1 2.1 0.344
3 2 4.2 0.149
>3 2 4.2 0.703
Regular NSAIDS intake (pills/mo) 0–5 41 85.4 2.966, 4, 0.564 —
6–10 5 10.4 0.946
11–15 2 4.2 0.270
16–20 0 0.0 0.999
>20 0 0.0 1.000
BMI = body mass index; df = degree of freedom; GERD = gastroesophageal reflux disease; NSAIDs = nonsteroidal antiinflammatory
drugs.
* p < 0.05; for the v2 or binary logistic regression test investigating the association between each risk factor and gastroesophageal
reflux disease.
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edge, this is the first study to investigate those
variables in Syria.
Many studies around the world have yielded dif-
ferent results about the prevalence of UD, IBS, andGERD; these differences are probably due to various
study populations, lifestyles, and different diagnos-
tic criteria. Older Asian studies used Rome I or Rome
II criteria to evaluate individuals for UD [10–12].
Studies that are more recent used ROME III criteria
292 T. Al Saadi et al.and estimated the prevalence of UD to be 1.6% in
Beijing, China [13], 5.67% in Zhejiang Province,
China [14], and 18% in India [15]. Our study showed
that the prevalence of UD among students in Damas-
cus reached 25%, which is relatively high compared
to other regional studies. Similarly, prevalence of
IBS was estimated to be 16.5% in India [15], 8.34%
in China [16], while prevalence of GERD was esti-
mated to be 15.6% in Japan [17]. Results from our
study were similar, with a prevalence of 17% for
IBS and 16% for GERD. Since IBS prevalence is more
frequent in young adults [18], the younger age of
our study participants may have contributed to the
elevated prevalence of IBS. Investigation for FD
would need performing endoscopy for all partici-
pants in order to exclude any possible structural
defects, according to Rome III criteria [5]. This kind
of study is not feasible in countries with limited
resources like Syria. However, since most people
with UDwill turn out to have FD [4], a rough estimate
for the prevalence of FD can be concluded.
Multiple lifestyle-related factors were shown to
be related to UD or IBS, including poor socioeco-
nomic status, smoking, alcohol, fatty food,
increased caffeine intake, and ingestion of nons-
teroidal antiinflammatory drugs [3,15,19]. Our
results revealed relationships between UD and both
cigarette and waterpipe smoking, as well as BMI.
While female gender and coffee intake were
related to IBS, cigarette smoking and tea intake
were related to GERD. The significant increase in
prevalence of IBS in females was expected because
functional GI disorders have a higher prevalence in
women [20]. Although not investigated, additional
risk factors, like diet, physical activity,
psychological factors, and type of faculty, may
have important effects on these GI disorders and
can be further investigated in future studies.
The data show a significant overlap between IBS,
UD, and GERD among the studied population. This
overlap was documented in several previous stud-
ies [21,22]. However, no precise mechanism for
this overlap was ascertained, and many theories
were suggested to explain it, including visceral
hypersensitivity and delayed gastric emptying
[23,24]. Jung et al. [21] concluded a higher than
expected overlap between IBS and GERD by com-
paring the observed prevalence to a calculated
prevalence that assumed no direct relationship
between those diseases. We have used a similar
approach to investigate the significance of the
overlaps between the studied disorders, and we
concluded similar observations.
Symptomatic diagnosis of GI disorders was found
to be confounded by the overlap among GIsymptoms [17]. It is important to consider this
issue when interpreting results of our study, partic-
ularly regarding UD–GERD overlap. In such an over-
lap, questionnaire-based differential diagnosis
cannot recognize those who have UD with underly-
ing GERD and who will be falsely diagnosed with
UD–GERD overlap.
The limitations of the study were as follows.
Firstly, the diagnosis of each of the three investi-
gated disorders lacks accuracy because it was
based on questionnaires without any further inves-
tigations. These disorders were investigated only
among students at Damascus University; results
may not be generalizable to the general population
of Damascus.
Secondly, the small sample size in this study may
have affected the generalizability of the results
and caused wide CI for risk estimates. Although it
has a small number of participants, the study can
be used as a pilot study to direct further research
with larger samples.5. Conclusion
Prevalences of UD, IBS, and GERD among students
of Damascus University were 25%, 17%, and 16%,
respectively. Significant overlaps were observed
between these three GI diseases. Multiple risk fac-
tors were found to be associated with each disease.
However, further research is needed in order to
provide a clearer understanding of the epidemiol-
ogy and risk factors for these diseases.
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